Dow, EPIcyte enter research, licensing agreement
The Dow Chemical Company and EPIcyte Pharmaceutical, Inc. of San Diego, announced that they have signed a research and licensing agreement to develop and produce monoclonal antibodies from plants.
The Dow Chemical Company and EPIcyte Pharmaceutical, Inc. of San Diego, announced that they have signed a research and licensing agreement to develop and produce monoclonal antibodies from plants.